Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Antibiotics, Antineoplastic/therapeutic use"'
Autor:
Maria S. Lindgren, Erik Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen
Publikováno v:
Skydt Lindgren, M, Hansen, E B, Azawi, N H, Munk Nielsen, A, Dyrskjøt, L & Jensen, J B 2023, ' DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial ', Journal of Clinical Oncology, vol. 41, no. 2, 41, pp. 206-211 . https://doi.org/10.1200/JCO.22.00470
PURPOSE This study aimed to assess long-term follow-up after chemoresection with mitomycin (MMC), a nonsurgical treatment modality for recurrent nonmuscle invasive bladder cancer (NMIBC). At the time of recurrence, chemoresection has previously been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae14f3fcdac801099e554f706c3f022a
https://pure.au.dk/portal/da/publications/dablaca13-study-oncological-outcome-of-shortterm-intensive-chemoresection-with-mitomycin-in-nonmuscle-invasive-bladder-cancer-primary-outcome-of-a-randomized-controlled-trial(e88f9de7-59e2-4940-b972-938bd9cba8dd).html
https://pure.au.dk/portal/da/publications/dablaca13-study-oncological-outcome-of-shortterm-intensive-chemoresection-with-mitomycin-in-nonmuscle-invasive-bladder-cancer-primary-outcome-of-a-randomized-controlled-trial(e88f9de7-59e2-4940-b972-938bd9cba8dd).html
Autor:
Colin A. Semple, Tzyvia Rye, Michael Churchman, Alison M. Meynert, Mark J. Arends, Andrew H. Sims, Robert L Hollis, Fiona Nussey, Melanie Mackean, Charlie Gourley, C. Simon Herrington
Publikováno v:
BMC Cancer
Hollis, R L, Meynert, A M, Churchman, M, Rye, T, Mackean, M, Nussey, F, Arends, M J, Sims, A H, Semple, C A, Herrington, C S & Gourley, C 2018, ' Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations ', BMC Cancer, vol. 18, no. 1, pp. 16 . https://doi.org/10.1186/s12885-017-3981-2
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Hollis, R L, Meynert, A M, Churchman, M, Rye, T, Mackean, M, Nussey, F, Arends, M J, Sims, A H, Semple, C A, Herrington, C S & Gourley, C 2018, ' Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations ', BMC Cancer, vol. 18, no. 1, pp. 16 . https://doi.org/10.1186/s12885-017-3981-2
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Background Approximately 10–15% of ovarian carcinomas (OC) are attributed to inherited susceptibility, the majority of which are due to mutations in BRCA1 or BRCA2 (BRCA1/2). These patients display superior clinical outcome, including enhanced sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96400cfe4b9d479a18a0495e22787eaa
https://doi.org/10.1186/s12885-017-3981-2
https://doi.org/10.1186/s12885-017-3981-2
We report a case of primary acquired corneal melanosis without atypia associated with corneal haze in a patient with a history of limbal malignant melanoma and the effect of mitomycin-C. A 75-year-old woman with a history of limbal malignant melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::01b4092d2672f2b40cdd4742bb905f16
F. M. MUGGIA When faced with the inadequacies of current cancer treatment, we prefer to look at what the future may hold. Quite often, we take for granted the past, preferring research into totally new areas. However, the persistent development of fe
Autor:
Evandro de Azambuja, Sherene Loi, Martine Piccart, Denis Larsimont, Angelo Di Leo, Marianne Paesmans, Ivana Bozovic-Spasojevic, Lieveke Ameye, Stella Dolci
Publikováno v:
Breast, 23 (4
Given recent data on genetic heterogeneity within and individual's tumor, we investigated if there were differences in the prognostic and predictive abilities of BCL2 and TP53 protein expression in primary breast cancer (TU) and corresponding axillar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3707fe5d6d6dc6189a80dc913e1039a
https://pubmed.ncbi.nlm.nih.gov/24768477
https://pubmed.ncbi.nlm.nih.gov/24768477
Publikováno v:
Journal of the National Cancer Institute
Background: Many systemic nonhormonal regimens have been evaluated across several hundreds of randomized trials in advanced breast cancer. We aimed to quantify the relative merits of these regimens in prolonging survival. Methods: We performed a syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f0853613352e7b34361be9679f7d8f
https://gnosis.library.ucy.ac.cy/handle/7/42158
https://gnosis.library.ucy.ac.cy/handle/7/42158
Autor:
Pentheroudakis, George, Fountzilas, George, Bafaloukos, Dimitrios, Koutsoukou, V., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Samantas, E., Kalofonos, H. P., Gogas, H., Pavlidis, Nicholas
Publikováno v:
Breast cancer research and treatment
Introduction. Breast cancer patients developing liver metastases have traditionally been considered to make up a poor prognosis group with median survival rates of less than 6 months. We retrospectively analysed clinicopathologic characteristics of 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1638f5225cdcc8746331a2ca1d9f66c
https://pubmed.ncbi.nlm.nih.gov/16322882
https://pubmed.ncbi.nlm.nih.gov/16322882
Autor:
Anna Kalogera-Fountzila, George Samelis, H. P. Kalofonos, George Fountzilas, Dimitrios Bafaloukos, C. Nicolaides, Gerasimos Aravantinos, Nicholas Pavlidis
Publikováno v:
Scopus-Elsevier
A phase II study was conducted to evaluate the activity and toxicity profile of the combination of docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer (ABC). Thirty-nine eligible patients with a median performance status of 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4eed2f0c3f607b967a5b40bd67a68d1
http://olympias.lib.uoi.gr/jspui/handle/123456789/22383
http://olympias.lib.uoi.gr/jspui/handle/123456789/22383
Autor:
Fountzilas, G., Nicolaides, C., Aravantinos, G., Skarlos, D., Kosmidis, P., Papakostas, P., Stathopoulos, G. P., Kontostolis, E., Bafaloukos, D., Pavlidis, N.
Forty-one patients with operable breast cancer and >/=10 positive axillary lymph nodes were treated with 6 cycles of dose-dense adjuvant chemotherapy consisting of epirubicin (100 mg/m2) every 2 weeks with G-CSF support. A total of 240 cycles were ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::5f36d2915837441ede462d0e10e5d557
http://olympias.lib.uoi.gr/jspui/handle/123456789/22357
http://olympias.lib.uoi.gr/jspui/handle/123456789/22357
Publikováno v:
泌尿器科紀要. 29(1):9-15
Eighty-eight cases of urinary bladder tumor were treated in our Department from 1976 to 1978. The effect of so-called immunopotentiators (OK-432, Levamisole and PSK) was studied in 23 patients. The following results were obtained. Pretreatment intrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::60a365d4a19eea1d4db0628c4b186cab
http://hdl.handle.net/2433/120107
http://hdl.handle.net/2433/120107